Health CareHealth Care Equipment & Services
  • Price (USD)101.03
  • Today's Change0.13 / 0.13%
  • Shares traded589.99k
  • 1 Year change-10.70%
  • Beta0.8518
Data delayed at least 15 minutes, as of Jun 25 2019 21:02 BST.
More ▼

Events & Activity

  • DGX:NYQ trading volume exceeds daily average by +60.84%
  • DGX:NYQ price moved over +1.06% to 101.40
  • DGX:NYQ price falls below 15-day moving average to 99.96 at 10:32 BST

Key statistics

On Tuesday, Quest Diagnostics Inc (DGX:NYQ) closed at 101.03, -13.27% below its 52-week high of 116.49, set on Jun 25, 2018.
52-week range
78.95Dec 26 2018116.49Jun 25 2018
Markit short selling activity
Previous close100.90
Average volume872.45k
Shares outstanding134.38m
Free float133.71m
P/E (TTM)19.79
Market cap13.58bn USD
EPS (TTM)5.11
Annual div (ADY)2.12
Annual div yield (ADY)2.10%
Div ex-dateApr 05 2019
Div pay-dateApr 22 2019
Next div ex-dateJul 05 2019
Next div pay-dateJul 22 2019
Data delayed at least 15 minutes, as of Jun 25 2019 21:02 BST.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.